Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kyverna Therapeutics
Biotech
Kyverna begins rolling FDA submission for autoimmune CAR-T in SPS
At the FDA's request, Kyverna will include additional analysis of a natural history study to contextualize miv-cel's benefit, CEO Warner Biddle said.
Angus Liu
May 12, 2026 4:27pm
Biopharma veteran takes her CEO Cue—Chutes & Ladders
May 8, 2026 8:30am
Kyverna’s full SPS data set stage for first autoimmune CAR-T nod
Apr 21, 2026 6:45pm
FDA to ‘carefully shepherd’ CAR-T for autoimmune disease: Prasad
Feb 3, 2026 11:40am
'Unprecedented' data prime Kyverna for 1st autoimmune CAR-T drug
Dec 15, 2025 10:55am
Kyverna links CAR-T to autoimmune improvements in small trial
Oct 29, 2025 10:00am
